Hypothesize That!
Hypothesize That!
✓

Gene Therapy’s Future: Will Patient Engagement Eclipse Science? | Hypothesize That!

00:29:35
Podcasts
RSS
Link

O TYM ODCINKU

Gene Therapy’s Future: Will Patient Engagement Eclipse Science? | Hypothesize That!

Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the critical role of patients in co-creating therapies that meet real-world needs, the ethical challenges of gene editing, and how early collaboration can build trust and transparency. Hear real-world insights into how patient voices are reshaping R&D—and how industry can embrace this paradigm shift.

 

 

This podcast is produced and funded by UCB.

Hosted on Acast. See acast.com/privacy for more information.


IE-OT-2500052 – July 2025

Hosted on Acast. See acast.com/privacy for more information.

Nauka
Zdrowie i fitness
Edukacja
Język angielski
Stany Zjednoczone
UżyjAPI, aby pobrać ten odcinek wJSON

W TYM ODCINKU

Edytuj te tagi

TRANSKRYPCJA 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki Hypothesize That!.
Umieść ten pasek wyszukiwania w swojej witrynie

INNE ODCINKI W TYM PODCASCIE

Smart Drugs, Dumb Trials: Rethinking the Foundations of Drug Development | Hypothesize That!

Smart Drugs, Dumb Trials: Rethinking the Foundations of Drug Development | Hypothesize That!

Are today’s clinical trials fit for the future of medicine, or are they holding innovation back?   In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Developme…
00:31:59
UDOSTĘPNIJ
ZAPISZ
Academic System vs Irreproducible Science | Hypothesize That! (CRIMES AGAINST INNOVATION)

Academic System vs Irreproducible Science | Hypothesize That! (CRIMES AGAINST INNOVATION)

In this special Crimes Against Innovation episode, host Nicola Hill hears two charges against the research system.   Professor Raj Chovatiya argues that the academic model is putting the brakes on innovation, squeezing creativity and collaboration. Meanwhile, Dr Joe Rastrick condemns the irre…
00:13:59
UDOSTĘPNIJ
ZAPISZ
Secrecy in Science vs. Risk-Averse Funding | Hypothesize That! (CRIMES AGAINST INNOVATION)

Secrecy in Science vs. Risk-Averse Funding | Hypothesize That! (CRIMES AGAINST INNOVATION)

Deep in the shadowy corridors of laboratories and the silent pages of medical journals, progress can falter, not for lack of brilliance, but because of the systems surrounding it. Ideas are delayed, discoveries are hidden, and bold thinking is quietly discouraged. This is Crimes Against Innovation.…
00:13:43
UDOSTĘPNIJ
ZAPISZ
Gender Bias in Trials vs. Five-to-Ten-Year Promise | Hypothesize That! (CRIMES AGAINST INNOVATION)

Gender Bias in Trials vs. Five-to-Ten-Year Promise | Hypothesize That! (CRIMES AGAINST INNOVATION)

In the darkened corridors of laboratories and the silent pages of medical journals, there are stories rarely spoken about—tales of brilliance that burned too bright, and ideas that strayed into catastrophe. This is—Crimes Against Innovation.   Laurence Woollard and Dr. Emma Lane debate two pre…
00:10:16
UDOSTĘPNIJ
ZAPISZ
Beyond One: How Will Multi-Specific Therapies Redefine Modern Medicine? | Hypothesize That!

Beyond One: How Will Multi-Specific Therapies Redefine Modern Medicine? | Hypothesize That!

In this episode, we ask a defining question: will multi-specific therapies revolutionize how we treat complex diseases? Host Nicola Hill is joined by Dr Joe Rastrick (UCB) and Professor Raj Chovatiya (Rosalind Franklin University) to examine whether medicines engineered to target multiple pathways …
00:30:35
UDOSTĘPNIJ
ZAPISZ
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z UCB Biopharma, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

REKOMENDACJE
Skorzystaj z API aby pobrać ten odcinek